{"id":"https://openalex.org/W2020765068","doi":"https://doi.org/10.1192/bjp.bp.114.148031","title":"Can psychedelic compounds play a part in drug dependence therapy?","display_name":"Can psychedelic compounds play a part in drug dependence therapy?","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2020765068","doi":"https://doi.org/10.1192/bjp.bp.114.148031","mag":"2020765068","pmid":"https://pubmed.ncbi.nlm.nih.gov/25561484"},"language":"en","primary_location":{"id":"doi:10.1192/bjp.bp.114.148031","doi":"https://doi.org/10.1192/bjp.bp.114.148031","is_oa":true,"landing_page_url":"https://doi.org/10.1192/bjp.bp.114.148031","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/514910FD07B84F71DC5099CCE76AA4E2/S0007125000237288a.pdf/div-class-title-can-psychedelic-compounds-play-a-part-in-drug-dependence-therapy-div.pdf","source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/514910FD07B84F71DC5099CCE76AA4E2/S0007125000237288a.pdf/div-class-title-can-psychedelic-compounds-play-a-part-in-drug-dependence-therapy-div.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081065269","display_name":"Ben Sessa","orcid":"https://orcid.org/0000-0002-1212-6060","observed_orcids":["https://orcid.org/0000-0002-1212-6060"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Ben Sessa","raw_affiliation_strings":["Ben Sessa, MBBS, MRCPsych, AddAction, Weston-Super-Mare, Cardiff University Medical School, UK; Matthew W. Johnson, PhD, Johns Hopkins School of Medicine, Baltimore, USA","Ben Sessa, MBBS, MRCPsych, AddAction, Weston-Super-Mare, Cardiff University Medical School, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ben Sessa, MBBS, MRCPsych, AddAction, Weston-Super-Mare, Cardiff University Medical School, UK; Matthew W. Johnson, PhD, Johns Hopkins School of Medicine, Baltimore, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I79510175"]},{"raw_affiliation_string":"Ben Sessa, MBBS, MRCPsych, AddAction, Weston-Super-Mare, Cardiff University Medical School, UK","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030387003","display_name":"Matthew W. Johnson","orcid":"https://orcid.org/0000-0001-7068-0513","observed_orcids":["https://orcid.org/0000-0001-7068-0513"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Matthew W. Johnson","raw_affiliation_strings":["Ben Sessa, MBBS, MRCPsych, AddAction, Weston-Super-Mare, Cardiff University Medical School, UK; Matthew W. Johnson, PhD, Johns Hopkins School of Medicine, Baltimore, USA","Matthew W. Johnson, PhD, Johns Hopkins School of Medicine, Baltimore, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ben Sessa, MBBS, MRCPsych, AddAction, Weston-Super-Mare, Cardiff University Medical School, UK; Matthew W. Johnson, PhD, Johns Hopkins School of Medicine, Baltimore, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I79510175"]},{"raw_affiliation_string":"Matthew W. Johnson, PhD, Johns Hopkins School of Medicine, Baltimore, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4920,"currency":"USD","value_usd":4920},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":58,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"206","issue":"1","first_page":"1","last_page":"3"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psychedelics","display_name":"psychedelics","score":0.7670000195503235},{"id":"https://openalex.org/keywords/drug-addiction","display_name":"drug addiction","score":0.7360000014305115},{"id":"https://openalex.org/keywords/psilocybin","display_name":"psilocybin","score":0.8700000047683716},{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":1.0},{"id":"https://openalex.org/keywords/ibogaine","display_name":"ibogaine","score":1.0},{"id":"https://openalex.org/keywords/ayahuasca","display_name":"ayahuasca","score":1.0},{"id":"https://openalex.org/keywords/addiction-treatment","display_name":"addiction treatment","score":0.7680000066757202}],"concepts":[{"id":"https://openalex.org/C2776502132","wikidata":"https://www.wikidata.org/wiki/Q208118","display_name":"Psilocybin","level":3,"score":0.947838306427002},{"id":"https://openalex.org/C2777066114","wikidata":"https://www.wikidata.org/wiki/Q380436","display_name":"Ayahuasca","level":2,"score":0.7966248989105225},{"id":"https://openalex.org/C124315065","wikidata":"https://www.wikidata.org/wiki/Q194270","display_name":"Hallucinogen","level":2,"score":0.7472360730171204},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5919508337974548},{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.4729207158088684},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.46734458208084106},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4477993845939636},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.44661352038383484},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4384306073188782},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3866897225379944},{"id":"https://openalex.org/C19165224","wikidata":"https://www.wikidata.org/wiki/Q23404","display_name":"Anthropology","level":1,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D006213","descriptor_name":"Hallucinogens","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1192/bjp.bp.114.148031","doi":"https://doi.org/10.1192/bjp.bp.114.148031","is_oa":true,"landing_page_url":"https://doi.org/10.1192/bjp.bp.114.148031","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/514910FD07B84F71DC5099CCE76AA4E2/S0007125000237288a.pdf/div-class-title-can-psychedelic-compounds-play-a-part-in-drug-dependence-therapy-div.pdf","source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:25561484","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25561484","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of psychiatry : the journal of mental science","raw_type":"Editorial"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:84499","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/84499/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1192/bjp.bp.114.148031","doi":"https://doi.org/10.1192/bjp.bp.114.148031","is_oa":true,"landing_page_url":"https://doi.org/10.1192/bjp.bp.114.148031","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/514910FD07B84F71DC5099CCE76AA4E2/S0007125000237288a.pdf/div-class-title-can-psychedelic-compounds-play-a-part-in-drug-dependence-therapy-div.pdf","source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2020765068.pdf","grobid_xml":"https://content.openalex.org/works/W2020765068.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1584908496","https://openalex.org/W1940682915","https://openalex.org/W1965591897","https://openalex.org/W1975552694","https://openalex.org/W1986013461","https://openalex.org/W1996143523","https://openalex.org/W2001298144","https://openalex.org/W2048859524","https://openalex.org/W2051521144","https://openalex.org/W2081812523","https://openalex.org/W2082540829","https://openalex.org/W2108222003","https://openalex.org/W2118739111","https://openalex.org/W2121977452","https://openalex.org/W2126283249","https://openalex.org/W2427846517","https://openalex.org/W4239734876","https://openalex.org/W4297953288","https://openalex.org/W6647005112"],"related_works":["https://openalex.org/W4404077742","https://openalex.org/W2557014604","https://openalex.org/W2583277970","https://openalex.org/W2725784961","https://openalex.org/W4400847605","https://openalex.org/W2325558246","https://openalex.org/W1981281259","https://openalex.org/W7151630586","https://openalex.org/W3187445852","https://openalex.org/W4402825425"],"abstract_inverted_index":{"After":[0],"a":[1,7],"40-year":[2],"hiatus":[3],"there":[4],"is":[5],"now":[6],"revisiting":[8],"of":[9,28,43],"psychedelic":[10],"drug":[11,29],"therapy":[12],"throughout":[13],"psychiatry,":[14],"with":[15,48],"studies":[16],"examining":[17],"the":[18,26,41],"drugs":[19],"psilocybin,":[20],"ketamine,":[21],"ibogaine":[22],"and":[23,38],"ayahuasca":[24],"in":[25],"treatment":[27],"dependence.":[30],"Limitations":[31],"to":[32,54],"these":[33],"therapies":[34],"are":[35],"both":[36],"clinical":[37],"legal,":[39],"but":[40],"possibility":[42],"improving":[44],"outcomes":[45],"for":[46],"patients":[47],"substance":[49],"dependency":[50],"imposes":[51],"an":[52],"obligation":[53],"research":[55],"this":[56],"area.":[57]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":11}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}